請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/61524
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 王錦堂(Jin-Town Wang) | |
dc.contributor.author | Han-Ru Yang | en |
dc.contributor.author | 楊涵如 | zh_TW |
dc.date.accessioned | 2021-06-16T13:04:58Z | - |
dc.date.available | 2018-09-24 | |
dc.date.copyright | 2013-09-24 | |
dc.date.issued | 2013 | |
dc.date.submitted | 2013-08-04 | |
dc.identifier.citation | Bera, A., Biswas, R., Herbert, S., and Gotz, F. (2006). The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infection and immunity 74, 4598-4604.
Bratcher, P.E., Kim, K.H., Kang, J.H., Hong, J.Y., and Nahm, M.H. (2010). Identification of natural pneumococcal isolates expressing serotype 6D by genetic, biochemical and serological characterization. Microbiology 156, 555-560. Calix, J.J., and Nahm, M.H. (2010). A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. The Journal of infectious diseases 202, 29-38. Cortes, G., Borrell, N., de Astorza, B., Gomez, C., Sauleda, J., and Alberti, S. (2002). Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infection and immunity 70, 2583-2590. Fung, C.P., Chang, F.Y., Lee, S.C., Hu, B.S., Kuo, B.I., Liu, C.Y., Ho, M., and Siu, L.K. (2002). A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut 50, 420-424. Harboe, Z.B., Benfield, T.L., Valentiner-Branth, P., Hjuler, T., Lambertsen, L., Kaltoft, M., Krogfelt, K., Slotved, H.C., Christensen, J.J., and Konradsen, H.B. (2010). Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 50, 329-337. Henrichsen, J. (1995). Six newly recognized types of Streptococcus pneumoniae. Journal of clinical microbiology 33, 2759-2762. Hestrin, S. (1949). The reaction of acetylcholine and other carboxylic acid derivatives with hydroxylamine, and its analytical application. The Journal of biological chemistry 180, 249-261. Ho, J.Y., Lin, T.L., Li, C.Y., Lee, A., Cheng, A.N., Chen, M.C., Wu, S.H., Wang, J.T., Li, T.L., and Tsai, M.D. (2011). Functions of some capsular polysaccharide biosynthetic genes in Klebsiella pneumoniae NTUH K-2044. PloS one 6, e21664. Hsieh, P.F., Lin, T.L., Lee, C.Z., Tsai, S.F., and Wang, J.T. (2008). Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. The Journal of infectious diseases 197, 1717-1727. Jenney, A.W., Clements, A., Farn, J.L., Wijburg, O.L., McGlinchey, A., Spelman, D.W., Pitt, T.L., Kaufmann, M.E., Liolios, L., Moloney, M.B., et al. (2006). Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development. Journal of clinical microbiology 44, 102-107. Kamerling, J.P., Lindberg, B., Lonngren, J., and Nimmich, W. (1975). Structural studies of the Klebsiella type 57 capsular polysaccharide. Acta chemica Scandinavica Series B: Organic chemistry and biochemistry 29, 593-598. Karkhanis, Y.D., Zeltner, J.Y., Jackson, J.J., and Carlo, D.J. (1978). A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Analytical biochemistry 85, 595-601. Ko, W.C., Paterson, D.L., Sagnimeni, A.J., Hansen, D.S., Von Gottberg, A., Mohapatra, S., Casellas, J.M., Goossens, H., Mulazimoglu, L., Trenholme, G., et al. (2002). Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerging infectious diseases 8, 160-166. Lin, J., Kaltoft, M.S., Brandao, A.P., Echaniz-Aviles, G., Brandileone, M.C., Hollingshead, S.K., Benjamin, W.H., and Nahm, M.H. (2006). Validation of a multiplex pneumococcal serotyping assay with clinical samples. Journal of clinical microbiology 44, 383-388. Link, A.J., Phillips, D., and Church, G.M. (1997). Methods for generating precise deletions and insertions in the genome of wild-type Escherichia coli: application to open reading frame characterization. Journal of bacteriology 179, 6228-6237. Lund, E., and Henrichsen, J. (1978). Laboratory diagnosis, serology and epidemiology of Streptococcus pneumoniae. Methods in microbiology, 241-262. Mizuta, K., Ohta, M., Mori, M., Hasegawa, T., Nakashima, I., and Kato, N. (1983). Virulence for mice of Klebsiella strains belonging to the O1 group: relationship to their capsular (K) types. Infection and immunity 40, 56-61. Naran, R., Chen, G., and Carpita, N.C. (2008). Novel rhamnogalacturonan I and arabinoxylan polysaccharides of flax seed mucilage. Plant physiology 148, 132-141. Pan, Y.J., Fang, H.C., Yang, H.C., Lin, T.L., Hsieh, P.F., Tsai, F.C., Keynan, Y., and Wang, J.T. (2008). Capsular polysaccharide synthesis regions in Klebsiella pneumoniae serotype K57 and a new capsular serotype. Journal of clinical microbiology 46, 2231-2240. Park, I.H., Pritchard, D.G., Cartee, R., Brandao, A., Brandileone, M.C., and Nahm, M.H. (2007). Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. Journal of clinical microbiology 45, 1225-1233. Rahn, A., and Whitfield, C. (2003). Transcriptional organization and regulation of the Escherichia coli K30 group 1 capsule biosynthesis (cps) gene cluster. Molecular microbiology 47, 1045-1060. Sikarwar, A.S., and Batra, H.V. (2011). Identification of Klebsiella Pneumoniae by Capsular Polysaccharide Polyclonal Antibodies. International Journal of Chemical Engineering and Applications 2, 130-134. Struve, C., Bojer, M., Nielsen, E.M., Hansen, D.S., and Krogfelt, K.A. (2005). Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1. Journal of medical microbiology 54, 1111-1113. Tsai, C.M., and Frasch, C.E. (1982). A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Analytical biochemistry 119, 115-119. Vinogradov, E., Frirdich, E., MacLean, L.L., Perry, M.B., Petersen, B.O., Duus, J.O., and Whitfield, C. (2002). Structures of lipopolysaccharides from Klebsiella pneumoniae. Eluicidation of the structure of the linkage region between core and polysaccharide O chain and identification of the residues at the non-reducing termini of the O chains. The Journal of biological chemistry 277, 25070-25081. Yang, F.L., Yang, Y.L., Liao, P.C., Chou, J.C., Tsai, K.C., Yang, A.S., Sheu, F., Lin, T.L., Hsieh, P.F., Wang, J.T., et al. (2011). Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae: activation of macrophages through Toll-like receptor 4. The Journal of biological chemistry 286, 21041-21051. Yu, J., Carvalho Mda, G., Beall, B., and Nahm, M.H. (2008). A rapid pneumococcal serotyping system based on monoclonal antibodies and PCR. Journal of medical microbiology 57, 171-178. Zartler, E.R., Porambo, R.J., Anderson, C.L., Chen, L.H., Yu, J., and Nahm, M.H. (2009). Structure of the capsular polysaccharide of pneumococcal serotype 11A reveals a novel acetylglycerol that is the structural basis for 11A subtypes. The Journal of biological chemistry 284, 7318-7329. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/61524 | - |
dc.description.abstract | 克雷伯氏肺炎桿菌是革蘭氏陰性菌,屬於腸內菌科,可引起多種社區及院內感染,造成如:肺炎、尿道炎與菌血症等,研究指出克雷伯氏肺炎桿菌所引起的不同感染症與細菌表面的莢膜醣類型態有一定的關係。本實驗室發展的噬菌體分型法是利用可辨識特異莢膜的噬菌體及其醣解酶進行莢膜分型,其中大部分的噬菌體和其醣解酶皆可敏感的辨識特異莢膜型所有的菌株,但從標準菌株K57 (ref. K57) 所分離的噬菌體ref-K57-1和其莢膜醣類分解酵素對於標準菌株K57及臨床菌株A1142有不同的辨識情形,也因此將莢膜型K57菌株分成兩群,並推測莢膜型K57可能存在同一莢膜型下的亞型。
臨床K57菌株外圍多醣的單醣組成測定,其單醣組成比例和已發表的標準菌株推測出的組成比例並無太大差異,推測噬菌體辨識差異可能是由於莢膜醣類修飾不同造成。另外,將莢膜型K57兩群的代表菌株其完整莢膜合成區基因做比較,發現臨床菌株A1142轉醯酶 (acyltransferase) 相關的基因被transposase插入,故此基因有被破壞的可能,然而標準菌株K57具有完整的轉醯酶基因,且經由1H核磁共振 (NMR)圖譜也顯示標準菌株K57與A1142莢膜上,僅有標準菌株K57的莢膜具有O-acetylation官能基修飾。接著探討莢膜多醣的差異是否影響這兩個菌株的致病力,研究證明A1142在小鼠體內的複製能力較ref. K57強,致病力較高。 更進一步探討在A1142的莢膜合成區內將標準菌株K57的完整轉醯酶基因進行補回或置換,並觀察其O-acylation表現量、噬菌體和醣解酶的辨識情形以及致病力是否改變。成功將標準菌株K57的轉醯酶補回的A1142及A1142 LPS突變菌株,其莢膜多醣上的O-acylation表現量均有提升,且醣解酶失去對轉醯酶補回的A1142 LPS突變菌株的辨識能力;完成基因置換的A1142 LPS突變菌株,結果與基因補回的A1142 LPS突變菌株一致。選擇CPS上O-acylation修飾程度與標準菌株K57相當的突變菌株,來研究轉醯酶是否影響細菌的致病力,以基因補回的A1142 LPS突變菌株進行體內競爭性實驗,發現此突變菌株在小鼠體內的致病力與野生型A1142相較降低許多。總結目前結果,A1142與標準菌株K57於噬菌體及其醣解酶辨識情形不同,可能由於A1142 的轉醯酶基因被破壞,進而影響在莢膜多醣上的O-acylation修飾,產生莢膜型K57的莢膜亞型導致醣解酶辨識差異,且擁有完整的轉醯酶使得A1142的致病力下降,影響標準菌株K57及A1142的致病能力差異可能與轉醯酶有關。 關鍵詞:克雷伯氏肺炎桿菌、社區型化膿性肝膿瘍、莢膜型K57、莢膜多醣亞型、轉醯酶 | zh_TW |
dc.description.abstract | Recently, Klebsiella pneumoniae has caused a new community-acquired emerging infectious disease, called pyogenic liver abscess, which has occurred in Taiwan and other areas. Capsular serotypes of K. pneumoniae closely associate with diseases.
We established a new capsular typing method by using capsular type-specific bacteriophages and their capsule depolymerases. All of the strains determined as capsular type K57 by cps PCR genotyping could be recognized by the capsule depolymerase isolated from ref. K57, but not ref. K57. K57 strains could be divided into two groups: A and B. Therefore, we suggested that K57 capsular type might have subtypes. In this study, we focused on capsular polysaccharide composition and cps sequence of two K. pneumoniae capsular type K57 strains: ref. K57 (A group) and A1142 (B group). At first, we investigated the sugar composition of two strains by GC-MS. There were no distinct differences between ref. K57 and A1142. Then, we sequenced and aligned the cps regions of them discovering a transposase inserted to a predicted acyltansferase gene of A1142, but not that of ref. K57. After that, 1H NMR spectrum also showed ref. K57 contained O-acetylation signals, but A1142 was not. Competition index indicated A1142 was more virulent than ref. K57 significantly. Furthermore, we studied whether the robust acyltransferase in A1142 capsular polysaccharide synthesis lead to changes of O-acylation level, bacteriophage/capsule depolymerase recognition and virulence. We discovered the capsule depolymerase lost the ability to recognize A1142 LPS mutant with acyltransferase complementation and replacement. After that, using the A1142 LPS mutant with acyltransferase complementation whose O-acylation level of CPS was almost equal to that of ref. K57 investigated the change of virulence by in vivo competition index. This result proved robust acyltransferase from ref. K57 in A1142 would decrease the bacterial load in BALB/c extremely. In conclusion, ref. K57 and clinical isolate A1142 have different O-acylation modification of CPS and acyltransferase in cps region. A1142 might be a subtype of capsular type K57 in K. pneumoniae. Acyltransferase was probably one of the reasons leading the different pathogenicity between ref. K57 and A1142. Keywords: Klebsiella pneumoniae, community-acquired pyogenic liver abscess (PLA), capsular serotype K57, capsular subtype, acyltransferase | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T13:04:58Z (GMT). No. of bitstreams: 1 ntu-102-R00445125-1.pdf: 1877599 bytes, checksum: 47427aa0d89339ad4f3e28e9c1d20925 (MD5) Previous issue date: 2013 | en |
dc.description.tableofcontents | 目錄
口試委員審定書 I 誌謝 II 中文摘要 III Abstract V 第一章、 緒論 1 1.1 克雷伯氏肺炎桿菌基本介紹 1 1.2 克雷伯氏肺炎桿菌噬菌體分型法與問題 2 1.3 肺炎鏈球菌新莢膜亞型 (subtype) 血清型定義 3 1.4 研究目的-證明有莢膜亞型的克雷伯氏桿菌 4 第二章、 材料與方法 6 2.1 實驗菌株 6 2.2 質體 6 2.3 聚合酶鏈鎖反應 (polymerase chain reaction, PCR) 6 2.4 噬菌體及其醣解酶塗點實驗 (spot test) 7 2.5 萃取克雷伯氏肺炎桿菌外圍醣類 7 2.6 酚-硫酸法 (phenol-sulfuric acid assay) 8 2.7 蛋白質定量 (Bradford assay) 8 2.8 單醣組成測定 8 2.9 脂多醣內的2-酮基-3-脫氧辛酸偵測 (KDO assay) 9 2.10 Carbazole assay 9 2.11 建構基因剔除 (unmarked deletion) 菌株 9 2.12 銀染 (silver stain) 10 2.13 體內競爭性分析 (in vivo competition index) 11 2.14 動物感染 (Animal inoculation) 11 2.15 熱酚水 (hot phenol-water) 萃取細菌外圍多醣體 (Exopolysaccharide, EPS) 11 2.16 硫酸定量莢膜多醣 (CPS)含量 12 2.17 胞外多醣O-acylation含量偵測 12 第三章、 實驗結果 13 3.1 克雷伯氏肺炎桿菌莢膜型K57噬菌體分型辨識情形 13 3.2 初步分析莢膜型K57之分群代表菌株其外圍多醣醣類組成 13 3.3 建立克雷伯氏肺炎桿菌之wecA基因剔除菌株 15 3.4 利用標準菌株 K57與A1142 (K57) 的wecA突變株再次分析外圍醣類的單醣組成 16 3.5 莢膜型K57的標準菌株與臨床菌株A1142之莢膜合成區基因比較 16 3.6 標準菌株K57與A1142 (K57) 莢膜多醣之O-acylation官能基分析 16 3.7 標準菌株K57與A1142在BALB/c的致病力 17 3.8 標準菌株K57的acyltransferase基因補回(complementation)的A1142菌株之莢膜多醣表現型分析 18 3.9 與標準菌株K57的acyltransferase基因置換 (replacement)的A1142 ΔwecA菌株之莢膜多醣表現型分析 19 3.10 改變莢膜多醣O-acylation修飾對於A1142菌株之致病力影響 19 第四章、 討論 21 第五章、 參考文獻 45 圖目錄 圖一、莢膜型K57標準菌株和臨床菌株外圍醣類單醣組成 25 圖二、膠體過濾法純化A1142 ( K57 )外圍醣類 26 圖三、標準菌株K57及A1142的wecA基因剔除菌株 27 圖四、標準菌株K57及A1142 (K57) wecA突變株莢膜多醣單醣組成測定 28 圖五、莢膜型K57標準菌株與臨床菌株A1142的莢膜合成區基因排列與比較 29 圖六、標準菌株K57 與A1142莢膜多醣之1H NMR圖譜 30 圖七、標準菌株K57與A1142的體內競爭性分析 31 圖八、ref. K57 acyltransferase基因補回 (complementation) 的A1142菌株 32 圖九、A1142的野生型及wecA突變株的acyltransferase基因補回菌株塗點測試 33 圖十、標準菌株K57和A1142及其突變株的O-acylation含量 34 圖十一、與ref. K57 acyltransferase基因置換 (replacement) 的A1142 ΔwecA菌株 35 圖十二、A1142 ΔwecA的acyltransferase基因置換 (replacement) 菌株之塗點測試 36 圖十三、A1142 ΔwecA的acyltransferase基因置換 (replacement) 菌株之O-acylation含量 37 圖十四、A1142 ΔwecA 與A1142 ΔwecA::r57acyl基因補回菌株的體內競爭性分析 38 表目錄 表一、本研究所使用之菌株和質體 39 表二、本研究所使用之引子 41 表三、莢膜型K57菌株噬菌體辨識情形及分群 43 表四、克雷伯氏肺炎桿菌標準菌株K57於BALB/c之LD50 44 | |
dc.language.iso | zh-TW | |
dc.title | 克雷伯氏肺炎桿菌K57莢膜亞型之發現與分析 | zh_TW |
dc.title | Identification and characterization of K57 capsular subtypes in Klebsiella pneumoniae | en |
dc.type | Thesis | |
dc.date.schoolyear | 101-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 林稚容(Tzu-Lung Lin),吳世雄 | |
dc.subject.keyword | 克雷伯氏肺炎桿菌,社區型化膿性肝膿瘍,莢膜型K57,莢膜多醣亞型,轉醯酶, | zh_TW |
dc.subject.keyword | Klebsiella pneumoniae,community-acquired pyogenic liver abscess (PLA),capsular serotype K57,capsular subtype,acyltransferase, | en |
dc.relation.page | 50 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2013-08-05 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 微生物學研究所 | zh_TW |
顯示於系所單位: | 微生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-102-1.pdf 目前未授權公開取用 | 1.83 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。